Company: SHPH
Filing Date: 2025-02-13
Form Type: S-1
Source: 0001493152-25-006202
Chunk: 241

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-13
Form: S-1
Chunk 241
---
 All of such costs and expenses are estimates, except for the SEC registration fee and the Financial Industry Regulatory Authority (“FINRA”) filing fee.

| SEC Filing Fees              |     | $ |
| FINRA Expenses               |     | $ |
| Accounting Fees and Expenses |     | $ |
| Legal Fees and Expenses      |     | $ |
| Transfer Agent Fees          |     | $ |
| Financial Printing Fees      |     | $ |
| Miscellaneous                
 Fees and Expenses            |     | $ |
| Total                        |     | $ |

All amounts are estimates other than the SEC and FINRA filing fees.

| ITEM 
 14.  | INDEMNIFICATION           
 OF DIRECTORS AND OFFICERS |

Section 145 of the Delaware General Corporation Law, as amended, authorizes us to indemnify any director or officer under certain prescribed circumstances and subject to certain limitations against certain costs and expenses, including attorney’s fees actually and reasonably incurred in connection with any action, suit or proceeding, whether civil, criminal, administrative or investigative, to which a person is party by reason of being one of our directors or officers if it is determined that such person acted in accordance with the applicable standard of conduct set forth in such statutory provisions. Our certificate of incorporation contains provisions relating to the indemnification of directors and officers and our by-laws extend such indemnities to the full extent permitted by Delaware law. We currently maintain insurance for the benefit of any director or officer which cover claims for which we could not indemnify such persons.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

| ITEM 
 15.  | RECENT                           
 SALES OF UNREGISTERED SECURITIES |

During the past three years, we effected the following transactions in reliance upon exemptions from registration under the Securities Act:

On December 28, 2021, in conjunction with entering into two loan agreements for a total of $500,000, which were repayable at the time of our IPO, we issued warrants to purchase a total of 500,000 shares of our common stock, exercisable at $1.00 per share (62,500 shares at $8.00 per share on a post -reverse split basis). Such warrants were sold to two accredited investors pursuant to an